Multiple immune cell populations and tissue-resident cells

The term "Multiple immune cell populations and tissue-resident cells" refers to a broad and heterogeneous collection of biological entities rather than a single molecular target. This classification encompasses various hematopoietic cells, such as T-lymphocytes, B-lymphocytes, and myeloid cells, as well as non-immune cells like fibroblasts and endothelial cells that reside within specific tissues (Source: NIH National Cancer Institute). Because this entry describes a cellular environment or a systemic population, it does not meet the criteria for a canonical therapeutic target like a specific receptor or enzyme. In drug discovery, targeting such a wide array of cells usually involves broad-acting immunomodulators or therapies that influence shared signaling pathways, such as cytokine receptors or checkpoint molecules (Source: Nature Reviews Drug Discovery). However, the lack of a discrete protein or gene identifier makes this entry "incorrect" for structured pharmacological databases. Analysts should instead focus on the specific molecular drivers within these populations, such as PD-1 on T cells or CSF1R on macrophages, to define a true therapeutic target. The biological functions of these populations are vast, ranging from pathogen defense and immune surveillance to tissue repair and the maintenance of homeostasis. Dysregulation within these cell groups is a hallmark of numerous conditions, including chronic inflammation, autoimmune disorders, and the progression of the tumor microenvironment in cancer.

Other names

Immune cell populationsTissue-resident immune cellsLeukocyte subsetsImmune cell milieu

Not applicable as this represents a cellular population rather than a discrete molecular target.